|Brand name(s), other common name(s)||Folotyn®|
|How the drug is given||Intravenously (IV)|
Pralatrexate is FDA approved to treat people who have relapsed or refractory peripheral T-cell lymphoma. It is being studied to treat people who have other forms of lymphoma including diffuse large B-cell lymphoma.
Side effects needing medical attention:Mouth sores; tiredness (fatigue); nausea; myelosuppression; infections.